This document is submitted by the Massachusetts Health Data Consortium (MHDC) and its Data Governance Collaborative (DGC) in response to the second NCVHS ICD-11 RFI posted in the Federal Register on October 16, 2023 and found here: https://www.federalregister.gov/documents/2023/10/16/2023-22753/national-committee-on-vital-and-health-statistics
Founded in 1978, MHDC, a not-for-profit corporation, convenes the Massachusetts’s health information community in advancing multi-stakeholder health data collaborations. MHDC’s members include payers, providers, industry associations, state and federal agencies, technology and services companies, and consumers. The Consortium is the oldest organization of its kind in the country.
MHDC provides a variety of services to its members including educational and networking opportunities, analytics services on both the administrative and clinical side (Spotlight), and data governance and standardization efforts for both clinical and administrative data (the Data Governance Collaborative/DGC and the New England Healthcare Exchange Network, respectively).
The DGC is a collaboration between payer and provider organizations convened to discuss, design, and implement data sharing and interoperability among payers, providers, patients/members, and other interested parties who need health data. It is a one stop interoperability resource. The DGC primarily focuses on three areas:
This section describes the Massachusetts-wide ICD-10 testing project run by MHDC and discusses how we think our experiences can help prepare for and improve the process of moving the healthcare community to ICD-11.
Starting in 2012 and running through the official industry adoption date for ICD-10, MHDC ran a Massachusetts-wide universal ICD-10 testing platform for payers and providers across the state. In addition to MHDC serving as the overall project manager, the project management team included the Massachusetts eHealth Collaborative (MAeHC) to assist with provider integrations and a national vendor to assist with payer integrations.
The project had three primary goals:
Overall, the project was a great success and we met these goals. 92 organizations participated in the testing including nearly every payer in Massachusetts, nearly all hospitals in Massachusetts (including behavioral health institutions), and several large provider groups. While smaller providers were given equal access, few of them took advantage of it, often citing lack of resources as the reason they did not participate.
Some of the key choices made around the scope of the project and use of ICD-10 codes included:
While the scope of the testing project was limited to the connectivity between trading partners, we found the benefits of joint testing extended well beyond that. In particular, the project provided a forum for airing out challenges organizations ran into within their black boxes, turning to the community to help them solve those problems, and learning how others dealt with the same or similar issues.
The biggest ask/concern from participants early in the project was assessing the impact of switching to ICD-10 on their revenue (for providers) or on payment integrity (for payers). We determined that it was not feasible to try to address these concerns in any realistic way for several reasons:
In general, familiar codes were given preference by providers and the smallest changes possible were usually implemented rather than trying to find some completely new solution even if it fit slightly better. Thus, only a subset of ICD-10 codes that most closely matched the ICD-9 codes already in place were used and tested.
In addition to reducing the work on both implementation and testing to a more manageable size, this also meant organizations focused on the most useful components of ICD-10 and did not have to worry about issues, incompatibilities, or how to map ICD-9 codes they were already using to more complex ICD-10 codes that might capture more information but required adjustments to existing workflows and provider practices.
In general, the lift for moving from ICD-9 to ICD-10 was heavier for payers than providers and it took them longer to complete their internal work in preparation for connectivity testing. This caused some churn with providers who were ready and chomping at the bit to start testing before their partners were ready to make the necessary connections.
The project involved individual testing pairs between each organization and all of its trading partners. This meant that no matter how fast a particular organization was ready to test, it could not complete its participation until the last of its trading partners was also ready.
This caused some resentment, but it also meant organizations had difficulty budgeting how long and how many ICD-10 resources they’d need because there was no clear, set timeframe and the readiness of various organizations was staggered. This was an issue for everyone, but was particularly difficult for providers waiting for payers as they tended to be ready sooner (as noted above).
Some additional concerns that were raised by participants throughout the project include:
The high level takeaways from the project include:
This section includes general comments on ICD-11 or comments on items that cross multiple questions in the RFIs.
We wish to thank NCVHS for providing a longer comment period on this RFI compared to the first ICD-11 RFI. We also appreciate the opportunity to respond to the questions from the previous RFI we were unable to address last summer in addition to the questions in the new RFI.
Participants in our Data Governance Collaborative strongly urge that any required US adoption of ICD-11 codes be carefully scheduled around other major regulatory requirements, particularly major interoperability rules from CMS and ONC or the upcoming changes to race and ethnicity data proposed by OMB. Each of these regulations comes with a significant lift and requires a major commitment of organizational resources to meet. It is extremely difficult to comply when multiple major updates or new functionality are required at the same time.
As ICD-11 has a compound code structure, it is important to be clear whether an entire composite code or a segment of the overall code is being referenced in any discussions, presentations, or written materials. In various presentations by NCVHS, NIH, and others, the term “code” has often used both for the entire composite value and for a single segment therein. We strongly recommend defining consistent usage expectations with different words representing the entire ICD-11 code vs a single segment/component of the overall composite value. We like “code” to represent the entire value and “segment” to represent a single component of the whole, but would welcome any consistently applied terminology that provided clarity between the two types of entities.
We realize these are likely not under the control of NCVHS, HHS, or anyone likely to see this comment, but our Data Governance Collaborative was struck by several of the choices made in the design and creation of ICD-11 codes.
Two issues stood out as extremely problematic to us:
This section will list specific questions asked about ICD-11 in the first NCVHS ICD-11 RFI and our responses to them.
Our Data Governance Collaborative discussion resulted in quite a few areas where we feel additional research or analysis would be helpful including:
We believe all of these areas are important. We are not familiar with what is and is not supportable via ICD-11 in the listed areas or similar types of health concerns. If supportable, some additional areas that are similar to some of those listed that might be important to capture include:
We believe the Office of the National Coordinator for Health IT (ONC), in coordination with other agencies within HHS as needed, is the right home for this oversight. Extensive feedback from industry and the public at large will also be essential, including public meetings and comment periods and explicit consultation and coordination with different types of providers, payers, vendors, and other relevant parties.
ONC is already responsible for other industry data standards such as USCDI and USCDI+. Further, there is already a process for collaborative standards definition with the USCDI+ framework. The existing ONDEC framework could be used to request updates for evaluation by ONC. If deemed appropriate, ONC could then submit these requests to WHO or their delegate for universal adoption.
A US linearization could be handled the same way, with annual or semi-annual updates released on a regular, predicable schedule using existing commenting and feedback processes.
ONC is also well positioned to ensure that new versions of the US linearization do not coincide with other major regulatory requirements such as deadlines for interoperability rules published by ONC or CMS.
It would be very nice to have a standard national mapping for ICD-10 to ICD-11. We understand that approximately 10% of ICD-10 codes cannot be directly mapped to ICD-11 so understanding which codes fall into this category and how to handle them in a standard way would also be extremely helpful.
In order to support FHIR and common FHIR use cases, it is absolutely essential to support mapping between ICD-11 and other code sets in a bi-directional, idempotent way if at all possible. The most useful mapping would definitely be between SNOMED and ICD-11, but mappings between ICD-11 and as many other code sets with compatible codes should be developed and made available for industry use.
This section will list specific questions asked about ICD-11 in the second NCVHS ICD-11 RFI and our responses to them.
We believe that a, b, and c would all be extremely useful. We do not have a good enough sense of what is possible with ICD-11 to comment beyond that.
It is unclear to us that there is a useful role for automation or AI related to the application of or upgrade to ICD-11. The quality of the underlying clinical documentation is extremely variable so using AI to analyze or process it is unlikely to be very successful.
However, as noted in comments above, it is important to provide useful, industry standard cross-maps between ICD-11 and other code systems, especially SNOMED.
We note that the application of ICD-11 codes and related processes are every bit as much human processes as tech processes. Education, workflow consistency and ease of use, training, and being aware of organizational culture will likely yield more positive results in terms of burden reduction than trying to automate everything, at least initially.
As noted in the previous comment, we believe that the human factor is a major component of this process. One of the key factors to be careful about here is the implementation timeframe. If the timeframe for implementation is too far out people will ignore it because it's not imminent, but at the same time it's clear it will take a long time to implement ICD-11. This will be a challenging area to get right, but it’s important. People will never believe they have enough time whatever choices are made here, so we believe it’s better to err on the side of a bit faster – but within the constraints of scheduling around other regulatory requirement deadlines. If needed, there’s always an option to use an enforcement delay to extend the implementation period.
We also note that clinicians usually don’t code using codes, they pick terminology. As long as the terminology doesn’t change significantly then clinicians likely won’t experience a huge change in workflows. Overall, it’s unclear how many folks at a provider office or other care setting interact directly with the codes rather than the related terminology. Updating the internal dictionary/mapping between codes and terminology is likely the largest lift at provider organizations.
We believe that everyone has a role to play in the adoption of ICD-11. As noted under the RFI #1 responses above, we believe ONC is the right organization to oversee ICD-11 in the US, but with coordination with CMS and other agencies within HHS as well as the industry and public at large. We were more focused on the definition and rules for maintenance and usage as well as related guidance in our thinking and did not consider all of the activities listed above (such as developing implementation plans which we see more as a local effort likely to be very different across different organizations) but some components of an overall program could be farmed out or sectioned off elsewhere with some oversight from ONC to maintain a single seat of authority if activities not in their direct wheelhouse are considered important.
Having a public-private partnership of some sort would be helpful, with some form of public meetings that go beyond invitation-only listening sessions seem warranted. It’s also important to involve different types of organizations and interest areas (payers, providers, vendors, data experts, revenue vs clinical, etc.).